Mucuna pruriens seeds in treatment of Parkinson's disease: Pharmacological review

被引:23
|
作者
Kasture S. [1 ,2 ]
Mohan M. [3 ]
Kasture V. [1 ,2 ]
机构
[1] Sanjivani College of Pharmaceutical Education and Research, Dist. Ahmednagar, Kopargaon
[2] Pinnacle Biomedical Research Institute, Bhopal
[3] Priyadarshini College of Pharmaceutical Sciences, Narapally, Chowdaryguda, Hyderabad
来源
关键词
Antioxidants; Genistein; Mucuna pruriens; Neuroprotective; Unsaturated acids;
D O I
10.1007/s13596-013-0126-2
中图分类号
学科分类号
摘要
Medicinal plants have been a rich source of medicines. Mucuna pruriens is extensively used in Ayurveda to treat kampavat (Parkinson's disease in modern medicine), a disease characterized by excess of Vata. Clinical and preclinical studies have substantiated claims on its efficacy and safety in PD and there are indications that it is more effective than the levodopa in reducing dyskinesias. Several constituents of Mucuna seeds such as genistein, gallic acid, unsaturated acids, nicotine, bufotenin, harmin alkaloids, lecithin, etc. have been isolated which possess neuroprotective activity and support the antiPD activity of levodopa. The review describes various constituents of Mucuna pruriens seeds in context to therapeutic utility in treating Parkinson's disease. Since the conventional treatment of PD using levodopa with other add-on drugs is very expensive and Mucuna pruriens seeds are easily available and economic, the use of standardized extract of Mucuna seeds may drastically reduce the cost of treatment and also reduce the progression of disease. The review emphasizes the importance of holistic approach of Ayurveda in using the Mucuna pruriens in treatment of PD. Further studies may provide an approach to understand the mechanisms involved in treating PD with lesser adverse effects. © 2013 Institute of Korean Medicine, Kyung Hee University.
引用
收藏
页码:165 / 174
页数:9
相关论文
共 50 条
  • [41] Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile
    Cassani, Erica
    Cilia, Roberto
    Laguna, Janeth
    Barichella, Michela
    Contin, Manuela
    Cereda, Emanuele
    Isaias, Ioannis U.
    Sparvoli, Francesca
    Akpalu, Albert
    Budu, Kwabena Ofosu
    Scarpa, Maria Teresa
    Pezzoli, Gianni
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 365 : 175 - 180
  • [42] Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E262 - E263
  • [43] EFFECT OF TEMPERATURE ON AFLATOXIN PRODUCTION IN MUCUNA-PRURIENS SEEDS
    ROY, AK
    CHOURASIA, HK
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1989, 55 (02) : 531 - 532
  • [44] Mucuna pruriens proves more effective than L-DOPA in Parkinson's disease animal model
    Hussain, G
    Manyam, BV
    PHYTOTHERAPY RESEARCH, 1997, 11 (06) : 419 - 423
  • [46] Darkening of white hair in Parkinson's disease during use of levodopa rich Mucuna pruriens extract powder
    Munhoz, Renato P.
    Teive, Helio A. G.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (02) : 133 - 133
  • [47] Mucuna pruriens in Parkinson disease A double-blind, randomized, controlled, crossover study
    Cilia, Roberto
    Laguna, Janeth
    Cassani, Erica
    Cereda, Emanuele
    Pozzi, Nicolo G.
    Isaias, Ioannis U.
    Contin, Manuela
    Barichella, Michela
    Pezzoli, Gianni
    NEUROLOGY, 2017, 89 (05) : 432 - 438
  • [48] Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective
    Rai, Sachchida Nand
    Chaturvedi, Vivek K.
    Singh, Payal
    Singh, Brijesh Kumar
    Singh, M. P.
    3 BIOTECH, 2020, 10 (12)
  • [50] Mucuna pruriens in Parkinson’s and in some other diseases: recent advancement and future prospective
    Sachchida Nand Rai
    Vivek K. Chaturvedi
    Payal Singh
    Brijesh Kumar Singh
    M. P. Singh
    3 Biotech, 2020, 10